Quotient Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.45M Sell
13,597
-419
-3% -$97.7K 0.08% 65
2026
Q1
$3.43M Buy
14,016
+540
+4% +$126K 0.09% 64
2025
Q4
$2.79M Buy
13,476
+104
+0.8% +$20.6K 0.07% 70
2025
Q3
$2.48M Buy
13,372
+896
+7% +$154K 0.07% 72
2025
Q2
$1.91M Sell
12,476
-335
-3% -$51.5K 0.06% 77
2025
Q1
$2.12M Buy
12,811
+714
+6% +$112K 0.07% 68
2024
Q4
$1.75M Sell
12,097
-1,250
-9% -$194K 0.06% 71
2024
Q3
$2.16M Buy
13,347
+125
+0.9% +$19.9K 0.07% 63
2024
Q2
$1.93M Sell
13,222
-8,130
-38% -$1.21M 0.07% 63
2024
Q1
$3.38M Sell
21,352
-6,198
-22% -$987K 0.12% 53
2023
Q4
$4.32M Buy
+27,550
New +$4.22M 0.17% 61

Other funds holding JNJ

Quotient Wealth Partners's JNJ Position: Q2 2026 in Review

Quotient Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 3% in Q2 2026, selling an estimated $97.7K and leaving 13,597 shares worth $3.45M. The position accounts for 0.08% of the portfolio, ranked #65.

Quotient Wealth Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.32M in Q4 2023. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Quotient Wealth Partners held 13,597 shares of Johnson & Johnson worth $3.45M as of Q2 2026.
  • Quotient Wealth Partners sold 419 Johnson & Johnson shares in Q2 2026, an estimated $97.7K.
  • Johnson & Johnson made up 0.08% of Quotient Wealth Partners's portfolio in Q2 2026, its #65 holding.
  • Quotient Wealth Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Quotient Wealth Partners's Johnson & Johnson position peaked at $4.32M in Q4 2023.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.